From: Five-year disease-free survival among stage II-IV breast cancer patients receiving FAC and AC chemotherapy in phase II clinical trials of Panagen
Chemotherapy + Placebo
Chemotherapy + Panagen
[38]
Patients
Survived patients
%
Survival, %
I
76.7
II
4
100
19
14
74
III
8
2
25
13
52
IV
3
0
7
Total
15
6
40
51
27
53